Child Passenger Deaths Stable in Crashes With Alcohol-Impaired Driver
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 6, 2024 -- The proportion of child passengers who died in crashes involving an alcohol-impaired driver has remained unchanged in the last decade, according to research published online Feb. 6 in Pediatrics.
Kyran Quinlan, M.D., M.P.H., from Rush University Medical Center in Chicago, and colleagues provided an update on child passenger deaths that involve an alcohol-impaired driver using national crash data from the 2011 to 2019 Fatality Analysis Reporting System Final Files and the 2020 Annual Report Files from the National Highway Traffic Safety Administration.
The researchers found that 7,944 child passengers died in motor vehicle traffic crashes from 2011 through 2020 in the United States, 22 percent of whom died in crashes involving an alcohol-impaired driver. Of those, 64 percent died while riding in the same vehicle as the alcohol-impaired driver. There was no meaningful change observed in the proportion who died in crashes involving an alcohol-impaired driver, but a modest increase was seen in the fatality rate of child passengers killed while riding with an impaired driver. When they died, most of these child passengers were unrestrained. Restraint use generally decreased with increases in the driver's blood alcohol concentration and child age. Overall, 69 percent of impaired drivers survived the crash that killed their child passenger. Most of these fatal crashes involved a single vehicle and occurred at night (60 and 65 percent, respectively).
"Existing laws to reduce alcohol-impaired driving need to be revised for effectiveness, and new measures specifically aimed at protecting child passengers endangered by their own impaired driver need to be developed and evaluated," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-07 04:15
Read more
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics
- Balancing on One Leg Is Most Reliable Measure of Neuromuscular Aging
- FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
- Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions